The Fast Trial

This trial recruited over 1900 asthma patients across UK (282 from Eastern region) and tested whether an asthma self-management plan that advised a temporary four-fold increase in the use of the steroid inhaler when asthma symptoms started to worsen, could prevent asthma exacerbations. Of the 957 participants in the four-fold group, 562 experienced worsening asthma symptoms and were advised to increase their inhaled steroid dose. In this group a reduction in asthma attacks was by about 20% compared to the usual care group. The results are published in the New England Journal of Medicine.